Effect of Omalizumab Therapy on Coagulation Parameters and Total Immunoglobulin E Levels in Patients with Chronic Idiopathic Urticaria and Bullous Pemphigoid

---

İncel Uysal P., Hayran Y., AKDOĞAN N., ÖKTEM A., Uğur Atılan A., GÜR AKSOY G., ...Daha Fazla

TURK DERMATOLOJI DERGISI, cilt.12, ss.159-166, 2018 (ESCI, Scopus, TRDizin)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 12
• Basım Tarihi: 2018
• Doi Numarası: 10.4274/tdd.3668
• Dergi Adı: TURK DERMATOLOJI DERGISI
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.159-166
• Anahtar Kelimeler: Anti-immunoglobulin E therapy, bullous pemphigoid, chronic urticaria, coagulation parameters, immunoglobulin E, omalizumab, DIMER PLASMA-LEVELS, BLOOD-COAGULATION, CLINICAL-RESPONSE, IGE, INFLAMMATION, AUTOIMMUNITY, ACTIVATION, DISEASE, MARKERS
• Ankara Üniversitesi Adresli: Hayır

Özet

Objective: The aim of this study is to assess the impact of omalizumab on coagulation biomarkers and immunoglobulin E (IgE) levels in chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) and bullous pemphigoid (BP) patients.